tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA

3.030USD

+0.040+1.34%
Horário de mercado ETCotações atrasadas em 15 min
4.95MValor de mercado
PerdaP/L TTM

Sonoma Pharmaceuticals Inc

3.030

+0.040+1.34%
Mais detalhes de Sonoma Pharmaceuticals Inc Empresa
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
Informações da empresa
Código da empresaSNOA
Nome da EmpresaSonoma Pharmaceuticals Inc
Data de listagemJan 26, 2007
CEOMs. Amy Trombly
Número de funcionários168
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 26
Endereço5445 Conestoga Court, Suite 150
CidadeBOULDER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80301
Telefone18007599305
Sitehttps://sonomapharma.com/
Código da empresaSNOA
Data de listagemJan 26, 2007
CEOMs. Amy Trombly
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bruce Thornton
Mr. Bruce Thornton
Chief Operating Officer, Executive Vice President, Corporate Secretary
Chief Operating Officer, Executive Vice President, Corporate Secretary
7.72K
-0.01%
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bruce Thornton
Mr. Bruce Thornton
Chief Operating Officer, Executive Vice President, Corporate Secretary
Chief Operating Officer, Executive Vice President, Corporate Secretary
7.72K
-0.01%
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Human Care
12.08M
84.54%
Animal Care
1.65M
11.57%
Service and Royalty
556.00K
3.89%
Por RegiãoUSD
Nome
Receita
Proporção
Europe
5.52M
38.65%
Latin America
2.96M
20.73%
United States
2.61M
18.27%
Asia
2.32M
16.22%
Rest of the world
875.00K
6.12%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Human Care
12.08M
84.54%
Animal Care
1.65M
11.57%
Service and Royalty
556.00K
3.89%
Distribuição de ações
Atualizado em: sáb, 26 de jul
Atualizado em: sáb, 26 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Geode Capital Management, L.L.C.
1.02%
HRT Financial LP
0.72%
Thornton (Bruce)
0.47%
Trombly (Amy Moss)
0.47%
The Vanguard Group, Inc.
0.41%
Other
96.91%
Investidores
Investidores
Proporção
Geode Capital Management, L.L.C.
1.02%
HRT Financial LP
0.72%
Thornton (Bruce)
0.47%
Trombly (Amy Moss)
0.47%
The Vanguard Group, Inc.
0.41%
Other
96.91%
Tipos de investidores
Investidores
Proporção
Individual Investor
1.28%
Investment Advisor
1.25%
Investment Advisor/Hedge Fund
1.02%
Hedge Fund
0.09%
Research Firm
0.06%
Other
96.30%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
39
60.82K
4.60%
-8.84K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
2023Q2
37
18.70K
7.42%
+4.13K
2023Q1
36
7.93K
3.54%
-8.20K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Geode Capital Management, L.L.C.
16.80K
1.02%
+16.80K
--
Mar 31, 2025
HRT Financial LP
11.84K
0.72%
+11.84K
--
Mar 31, 2025
Thornton (Bruce)
7.72K
0.47%
+2.68K
+53.16%
Jun 21, 2024
Trombly (Amy Moss)
7.68K
0.47%
+2.68K
+53.58%
Jun 21, 2024
The Vanguard Group, Inc.
6.67K
0.41%
--
--
May 31, 2025
Dvonch (Jerome J)
4.23K
0.26%
+2.68K
+172.90%
Jun 21, 2024
UBS Financial Services, Inc.
1.85K
0.11%
-15.58K
-89.37%
Mar 31, 2025
Tower Research Capital LLC
1.45K
0.09%
-960.00
-39.88%
Mar 31, 2025
Dal (Poggetto John)
910.00
0.06%
+910.00
--
Jun 20, 2024
Citi Investment Research (US)
811.00
0.05%
+811.00
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Data
Tipo
Proporção
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
KeyAI